litlas
Log inCreate account

Michael P. Whyte

Active 1969–2024

122
Papers
23,004
Citations
88
h-index
120
i10-index

Citations

Citations per year for Michael P. Whyte1971: 1 citations1976: 1 citations1977: 1 citations1980: 2 citations1981: 3 citations1982: 4 citations1983: 1 citations1984: 14 citations1985: 8 citations1986: 8 citations1987: 8 citations1988: 14 citations1989: 18 citations1990: 19 citations1991: 29 citations1992: 37 citations1993: 9 citations1994: 27 citations1995: 36 citations1996: 21 citations1997: 41 citations1998: 45 citations1999: 53 citations2000: 67 citations2001: 56 citations2002: 73 citations2003: 103 citations2004: 108 citations2005: 113 citations2006: 115 citations2007: 180 citations2008: 125 citations2009: 124 citations2010: 157 citations2011: 143 citations2012: 199 citations2013: 193 citations2014: 152 citations2015: 187 citations2016: 216 citations2017: 249 citations2018: 134 citations2019: 524 citations2020: 689 citations2021: 500 citations2022: 365 citations2023: 227 citations2024: 376 citations2025: 213 citations2026: 3 citations1972–1975: no citations, so these years are not shown1978–1979: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,688 citing papers, 28.4% of this breakdownUnited Kingdom: 621 citing papers, 10.4% of this breakdownCanada: 329 citing papers, 5.5% of this breakdownGermany: 314 citing papers, 5.3% of this breakdownItaly: 277 citing papers, 4.7% of this breakdownFrance: 271 citing papers, 4.6% of this breakdownJapan: 235 citing papers, 3.9% of this breakdownChina: 232 citing papers, 3.9% of this breakdownAustralia: 197 citing papers, 3.3% of this breakdownNetherlands: 161 citing papers, 2.7% of this breakdownSpain: 154 citing papers, 2.6% of this breakdownBelgium: 129 citing papers, 2.2% of this breakdown
0%28.4%Other 22.5%

Institutions

Fields

  • Medicine61.9%
  • Biochemistry, Genetics and Molecular Biology32%
  • Neuroscience1.6%
  • Engineering1%
  • Nursing0.9%
  • Immunology and Microbiology0.7%
  • Other1.9%

Topics

  • Bone health and treatments7.3%
  • Bone health and osteoporosis research6.3%
  • Parathyroid Disorders and Treatments5.3%
  • Alkaline Phosphatase Research Studies4.5%
  • Bone Metabolism and Diseases4.3%
  • Bone and Joint Diseases2.7%
  • Other69.6%

Coauthors

All papers

Open in search
  1. Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research

    Authors: Elizabeth Shane, David B. Burr, Bo Abrahamsen, Robert A. Adler, Thomas D. Brown, Angela M. Cheung, Felicia Cosman, Jeffrey R. Curtis, Richard Dell, David W. Dempster, Peter R. Ebeling, Thomas A. Einhorn, Harry K. Genant, Piet Geusens, Klaus Klaushofer, Joseph M. Lane, Fergus McKiernan, Ross E. McKinney, Alvin Choong Meng Ng, Jeri W. Nieves, Regis J. O’Keefe, Socrates E. Papapoulos, Tet Sen Howe, Marjolein C. H. van der Meulen, Robert S. Weinstein, Michael P. Whyte - Journal of Bone and Mineral Research 2013 cited by 2,118

  2. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

    Authors: Erik A. Imel, Francis H. Glorieux, Michael P. Whyte, Craig F. Munns, Leanne M. Ward, Ola Nilsson, Jill H. Simmons, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary S. Gottesman, Andrew Biggin, Farzana Perwad, Meng Mao, Chao-Yin Chen, Alison Skrinar, Javier San Martín, Anthony A. Portale - The Lancet 2019 cited by 367

  3. Burosumab Therapy in Children with X-Linked Hypophosphatemia

    Authors: Thomas O. Carpenter, Michael P. Whyte, Erik A. Imel, Annemieke M. Boot, Wolfgang Högler, Agnès Linglart, Raja Padidela, William van’t Hoff, Meng Mao, Chao-Yin Chen, Alison Skrinar, Emil Kakkis, Javier San Martín, Anthony A. Portale - New England Journal of Medicine 2018 cited by 473

  4. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein

    Authors: Giles D. Watts, Jill Wymer, Margaret J. Kovach, Sarju Mehta, Steven Mumm, Daniel Darvish, Alan Pestronk, Michael P. Whyte, Virginia Kimonis - Nature Genetics 2004 cited by 1,398

  5. Hypophosphatasia — aetiology, nosology, pathogenesis, diagnosis and treatment

    Authors: Michael P. Whyte - Nature Reviews Endocrinology 2016 cited by 500

  6. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

    Authors: Jenny C. Taylor, Hilary C. Martin, Stefano Lise, John Broxholme, Jean‐Baptiste Cazier, Andy Rimmer, Alexander Kanapin, Gerton Lunter, Simon Fiddy, Chris Allan, A.R. Aricescu, Moustafa Attar, Christian Babbs, Jennifer Becq, David Beeson, Celeste Bento, P Bignell, Edward Blair, Veronica J. Buckle, Katherine R. Bull, Ondřej Cais, Holger Cario, Helen Chapel, Richard R. Copley, Richard J. Cornall, Jude Craft, Karin Dahan, Emma E. Davenport, Calliope A. Dendrou, Olivier Devuyst, Aimée L Fenwick, Jonathan Flint, Lars Fugger, Rodney D. Gilbert, Anne Goriely, Angie Green, Ingo H. Greger, Russell Grocock, Anja V. Gruszczyk, Robert Hastings, Edouard Hatton, Douglas R. Higgs, Adrian V. S. Hill, Chris Holmes, Malcolm F. Howard, Linda Hughes, Peter Humburg, David H. Johnson, Fredrik Karpe, Zoya Kingsbury, Usha Kini, Julian C. Knight, Jonathan Krohn, Sarah Lamble, Craig B. Langman, Lorne Lonie, Joshua Luck, Davis J. McCarthy, Simon J. McGowan, Mary Frances McMullin, Kerry A. Miller, Lisa Murray, Andrea H. Németh, M. Andrew Nesbit, David Nutt, Elizabeth Ormondroyd, Annette Oturai, Alistair T. Pagnamenta, Smita Y. Patel, Melanie J. Percy, Nayia Petousi, Paolo Piazza, Siân E. Piret, Guadalupe Polanco‐Echeverry, Niko Popitsch, Fiona Powrie, Christopher W. Pugh, Lynn Quek, Peter A. Robbins, Kathryn Robson, Alexandra Russo, Natasha Sahgal, Pauline A. van Schouwenburg, Anna Schuh, Earl D. Silverman, Alison Simmons, Per Soelberg Sørensen, Elizabeth Sweeney, John Taylor, Rajesh V. Thakker, Ian Tomlinson, Amy Trebes, Stephen R.F. Twigg, Holm H. Uhlig, Paresh Vyas, Tim J. Vyse, Steven A. Wall, Hugh Watkins, Michael P. Whyte, Lorna Witty and 10 more - Nature Genetics 2015 cited by 388

  7. Efficacy and safety of burosumab in children aged 1–4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial

    Authors: Michael P. Whyte, Thomas O. Carpenter, Gary S. Gottesman, Meng Mao, Alison Skrinar, Javier San Martín, Erik A. Imel - The Lancet Diabetes & Endocrinology 2019 cited by 182

  8. Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia

    Authors: Agnès Linglart, Erik A. Imel, Michael P. Whyte, Anthony A. Portale, Wolfgang Högler, Annemieke M. Boot, Raja Padidela, William van’t Hoff, Gary S. Gottesman, Angel Chen, Alison Skrinar, Mary Scott Roberts, Thomas O. Carpenter - The Journal of Clinical Endocrinology & Metabolism 2021 cited by 89

  9. Alkaline Phosphatase and Hypophosphatasia

    Authors: José Luís Millán, Michael P. Whyte - Calcified Tissue International 2015 cited by 393

  10. Enzyme-Replacement Therapy in Life-Threatening Hypophosphatasia

    Authors: Michael P. Whyte, Cheryl R. Greenberg, Nada Salman, Michael B. Bober, William H. McAlister, Deborah Wenkert, Bradley J. Van Sickle, Jill H. Simmons, Terence S. Edgar, Martin Bauer, Mohamed A. Hamdan, Nick Bishop, Richard E. Lutz, Mairead McGinn, Stanley Craig, Jean N. Moore, John W. Taylor, Robert Cleveland, William R. Cranley, Ruth Lim, Tom D. Thacher, J. Mayhew, Matthew Downs, José Luís Millán, Alison Skrinar, Philippe Crine, Hal Landy - New England Journal of Medicine 2012 cited by 566

  11. Hypophosphatasia: An overview For 2017

    Authors: Michael P. Whyte - Bone 2017 cited by 240

  12. Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia

    Authors: Leanne M. Ward, Francis H. Glorieux, Michael P. Whyte, Craig F. Munns, Anthony A. Portale, Wolfgang Högler, Jill H. Simmons, Gary S. Gottesman, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Ola Nilsson, Meng Mao, Angel Chen, Alison Skrinar, Mary Scott Roberts, Erik A. Imel - The Journal of Clinical Endocrinology & Metabolism 2022 cited by 76

  13. Hypophosphatasia: Validation and expansion of the clinical nosology for children from 25years experience with 173 pediatric patients

    Authors: Michael P. Whyte, Fan Zhang, Deborah Wenkert, William H. McAlister, Karen Mack, Marci C. Benigno, Stephen P. Coburn, Susan Wagy, Donna M. Griffin, Karen L. Ericson, Steven Mumm - Bone 2015 cited by 262

  14. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia

    Authors: Michael P. Whyte, Cheryl R. Greenberg, Keiichi Ozono, Richard J. Riese, Scott Moseley, Agustin Melian, David D. Thompson, Nicholas Bishop, Christine Hofmann - The Journal of Clinical Endocrinology & Metabolism 2015 cited by 265

  15. Alkaline Phosphatase: Discovery and Naming of Our Favorite Enzyme

    Authors: Alejandro F. Siller, Michael P. Whyte - Journal of Bone and Mineral Research 2017 cited by 130

  16. Skeletal and extraskeletal disorders of biomineralization

    Authors: Michael T. Collins, Gemma Marcucci, Hans‐Joachim Anders, Giovanni Beltrami, Jane A. Cauley, Peter R. Ebeling, Rajiv Kumar, Agnès Linglart, Luca Sangiorgi, Dwight A. Towler, Ria Weston, Michael P. Whyte, Maria Luisa Brandi, B.L. Clarke, Rajesh V. Thakker - Nature Reviews Endocrinology 2022 cited by 66

  17. Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia

    Authors: Lothar Seefried, Priya S. Kishnani, Scott Moseley, Andrew Denker, Eric Watsky, Michael P. Whyte, Kathryn Dahir - Bone 2020 cited by 39

  18. Alkaline Phosphatase Knock-Out Mice Recapitulate the Metabolic and Skeletal Defects of Infantile Hypophosphatasia

    Authors: K N Fedde, Libby A. Blair, Julie Silverstein, Stephen P. Coburn, Lawrence M. Ryan, Robert S. Weinstein, Katrina G. Waymire, Sonoko Narisawa, José Luís Millán, Grant R. MacGregor, Michael P. Whyte - Journal of Bone and Mineral Research 1999 cited by 400

  19. Enzyme Replacement Therapy for Murine Hypophosphatasia

    Authors: José Luís Millán, Sonoko Narisawa, Isabelle Lemire, Thomas P. Loisel, Guy Boileau, Pierre Léonard, Svetlana Gramatikova, Robert Terkeltaub, Nancy P. Camacho, Marc D. McKee, Philippe Crine, Michael P. Whyte - Journal of Bone and Mineral Research 2007 cited by 259

  20. Asfotase alfa therapy for children with hypophosphatasia

    Authors: Michael P. Whyte, Katherine L. Madson, Dawn Phillips, Amy Reeves, William H. McAlister, Amy Yakimoski, Karen Mack, Kim Hamilton, K. G. Kagan, Kenji P. Fujita, David D. Thompson, Scott Moseley, Tatjana Odrljin, Cheryl R. Greenberg - JCI Insight 2016 cited by 172

  21. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial

    Authors: Michael P. Whyte, Jill H. Simmons, Scott Moseley, Kenji P. Fujita, Nicholas Bishop, Nada Salman, John W. Taylor, Dawn Phillips, Mairead McGinn, William H. McAlister - The Lancet Diabetes & Endocrinology 2018 cited by 145

  22. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia

    Authors: Priya S. Kishnani, Cheryl R. Greenberg, Frank Rauch, M. Tariq Bhatti, Scott Moseley, Andrew Denker, Eric Watsky, Michael P. Whyte - Bone 2018 cited by 144

  23. AP2σ Mutations Impair Calcium-Sensing Receptor Trafficking and Signaling, and Show an Endosomal Pathway to Spatially Direct G-Protein Selectivity

    Authors: Caroline M. Gorvin, Angela Rogers, Benoît Hastoy, Andrei I. Tarasov, Morten Frost, Silvia Sposini, Asuka Inoue, Michael P. Whyte, Patrik Rorsman, Aylin C. Hanyaloglu, Gerda E. Breitwieser, Rajesh V. Thakker - Cell Reports 2018 cited by 91

  24. Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia

    Authors: Raja Padidela, Michael P. Whyte, Francis H. Glorieux, Craig F. Munns, Leanne M. Ward, Ola Nilsson, Anthony A. Portale, Jill H. Simmons, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary S. Gottesman, Andrew Biggin, Farzana Perwad, Angela Williams, Annabel Nixon, Wei Sun, Angel Chen, Alison Skrinar, Erik A. Imel - Calcified Tissue International 2021 cited by 48